Browse our collection of papers in
GlaxoSmithKline (GSK)
C/F/973. Credit Rating Analysis of GlaxoSmithKline
- WORDS:
- 1600
- DATE:
- 2010
- PRICE:
- 19.99 GBP
The paper looks at the rating agencies that provide ratings on credit worthiness of companies. The relevance of the rating industry is examined discussing the fairness and accuracy of the ratings. A case study is conducted comparing credit rating analysis of GlaxoSmithKline (GSK) given by the two rating agencies on the basis of the company’s financial ratios. Financial risks embedded in the GSK profile are defined, financial challenges of the pharmaceutical industry are discussed.
KEYWORDS: Credit Rating, rating agency, GlaxoSmithKline, GSK, financial ratios,
Other Papers On: GlaxoSmithKline (GSK)
Other Papers On: Financial Analysis
Subject Catalogue
- Dissertations and Proposals
- Analysis of Companies
- Analysis of Industries
- Architecture, Design and Technology
- Computing and Mathematics
- E-Commerce and E-Business
- Economics
- Education
- Engineering
- Fashion and Culture
- Finance and Accounting
- General Business
- History
- Hospitality and Tourism
- Human Resource Management
- International Relations
- Law
- Literature, Language and Theatre Studies
- Management and Organisational Behaviour
- Marketing
- Media, Music and Art
- Operations Management
- Philosophy
- Politics
- Psychology
- Science, Medicine and Nursing
- Sociology
Keywords Tag Cloud
glaxosmithkline gsk management merger dissertation strategic financial pharmaceutical mergers plc om change pestel swot value study wellcome beecham glaxo performance aquafresh operations smithkline chain bring desired acquisition porter forces corporate effects astrazeneca proposal strategy global glaxowellcome uk system stock quality managing social market organisational johnson vs molecular audit innovation swine clinical safety intelligence flu impact newspaper responsibility publicity environmental disclosures annual shoeshine reports issues production vaccines faced healthcare shoring credit rating capability operational investment opportunities marketing mix competitive environment phytopharm organisations reasons measuring capm security theory disaster novartis companies pfizer studies hr model india arising challenges communication directions economic project innovations methodology systems critique soft role development critical approach process speeding implementation lean knowledge culture investigation risk entrepreneurship control glaxosmithklein equilibrium share price negotiation harbin property intellectual valuation backgrounds benefits petroleum stocks british construction company portfolio acquisitions pharmaceuticals prediction using smithline post pre final benefit overview international options position comparative current finance master glaxosmithklines c return announcement effect technical
GET OUR GooGLE TOOLBAR BUTTON
BOOK MARK US
WHAT OTHERS HAVE SAID
Yes, thanks I received the paper. That was quick!Cheng
